Amaurosis Fugax: Clinical Trials

3 trials for Amaurosis Fugax, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1

Follow Amaurosis Fugax: new trials by email Literature Review of Amaurosis Fugax trials Research Report on Amaurosis Fugax

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ocular Manifestations in Rheumatic Diseases
No intervention used - Uveitis, Conjunctivitis
CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's50002013-05-012022-04-12
Revacept in Symptomatic Carotid Stenosis
Revacept, Placebo - Carotid Stenosis, Atherosclerosis
Phase 2CompletedAdvanceCor GmbH1582013-03-082021-01-28
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
RX Acculink Carotid Stent System (RX Acculink) - Carotid Artery Disease, Stroke
Not applicableCompletedAbbott Medical Devices12032011-10-012016-08-12

Narrower conditions

Ischemic Attack, Transient (2)  ·  Stroke (2)  ·  Atherosclerosis (1)  ·  Blindness (1)  ·  Carotid Artery Diseases (1)  ·  Carotid Stenosis (1)  ·  Chorioretinitis (1)  ·  Choroid Hemorrhage (1)  ·  Conjunctivitis (1)  ·  Eye Hemorrhage (1)  ·  Iridocyclitis (1)  ·  Keratoconjunctivitis Sicca (1)  ·  Macular Edema (1)  ·  Optic Neuritis (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Eye Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Vision Disorders (3)  ·  Arterial Occlusive Diseases (2)  ·  Blindness (2)  ·  Brain Diseases (2)  ·  Brain Ischemia (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)

Interventions

Control Groups (1)  ·  Revacept (1)

Sponsors

Abbott Medical Devices (1)  ·  AdvanceCor GmbH (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

Germany (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

D. Christopher Metzger, MD (1)  ·  Holger Poppert, Prof. Dr. (1)  ·  Ian M Loftus, MD (1)  ·  Janet Pope, MD (1)

Results publications

PMID 35695006